Key result
Older people with stable CVD had impaired overall health-related quality of life compared to an age- and gender-matched general population.
Why the study?
CVD and thyroid dysfunction are common in older people, but little is known about how they affect health-related quality of life.
Does stable CVD and levothyroxine substitution affect health-related quality of life in older patients?
Cross-Sectional (n=432)
No
Does stable CVD and levothyroxine substitution affect health-related quality of life in older patients?
Older people with stable CVD have impaired health-related quality of life compared to the general population, and levothyroxine substitution is associated with further negative impacts on sleep and sexual activity.
Answers are grounded in this paper and cite their sources.
Impaired HRQoL in older stable CVD patients merits clinical attention; leaves open levothyroxine's independent effects.
BACKGROUND: Cardiovascular disease (CVD) and thyroid dysfunction are common in older people, but little is known about how they affect health-related quality of life (HRQoL). METHODS: We assessed HRQoL with the 15D instrument in 329 home-dwelling patients aged ≥ 75 years with stable CVD and compared the results to those of an age- and gender-matched general population (n = 103). We also studied the impact of age, BMI, number of medications, thyroid-stimulating hormone (TSH) concentration, levothyroxine (L-T4) substitution and Mini-Mental State Examination (MMSE) on HRQoL. RESULTS: Overall HRQoL was impaired in older people with stable CVD (mean 15D score 0.777 vs 0.801, p = 0.001), and also on single dimensions of breathing, sleeping, discomfort and symptoms, distress, vitality (all p < 0.001), and depression (p = 0.016) compared to the age- and gender-matched general population. Furthermore, in the patients, L-T4 substitution associated with impaired sleeping (p = 0.018) and sexual activity (p = 0.030). Moreover, MMSE points, number of medications used, age (all p < 0.001) and BMI (p = 0.009) predicted impaired HRQoL. CONCLUSIONS: Older people with stable CVD are characterized by impaired HRQoL compared to age- and gender-matched controls. We demonstrate that this is the consequence of impaired breathing, sleeping, discomfort and symptoms, distress, vitality, and depression. L-T4 substitution has a negative impact on HRQoL in old patients with stable CVD. MMSE score, number of medications, age and BMI predict worse HRQoL.
No takes yet. Share an insight, caveat, or question.
Ojala et al. (2020) conducted a cross-sectional in Stable Cardiovascular Disease (CVD) (n=432). Stable CVD vs. Age- and gender-matched general population was evaluated on Overall health-related quality of life (mean 15D score) (p=0.001). Older people with stable CVD had impaired overall health-related quality of life compared to an age- and gender-matched general population.
Synapse has enriched 10 related papers. Consider them for comparative context: